Biden’s $7 billion price tag on plan to limit fallout from drug pricing changes

Published



A plan from the Biden-Harris administration to lower insurance premium prices for seniors could cost more than $7 billion next year and $21 billion through 2027, according to a new report from the Congressional Budget Office. 

Republican lawmakers say the program to subsidize Medicare Part D prescription drug plans, announced this summer by the Centers for Medicare and Medicaid Services, is an attempt by Democrats to hide the rising costs of healthcare during the 2024 election.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.